2004-06-16 - Female - 29 Years old
171933
| Adverse reaction report number | 171933 |
| Latest AER version number | 0 |
| Market authorization holder AER number | N/A |
| Initial received date | 2004-06-16 |
| Latest received date | 2004-06-16 |
| Age | 29 Years |
| Gender | Female |
| Weight | 73 Kilograms |
| Type of report | Spontaneous |
| Reporter type | Pharmacist |
| Source of report | Community |
| Report outcome | Recovered/resolved |
| Serious report? | Yes |
Reason for seriousness
| Death | |
| Disability | |
| Cogenital anomaly | |
| Life threateting | |
| Hospitalization | Yes |
| Other medically important |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 20 Milligram | 1 every 1 Day(s) | 2 Day(s) | |
| ACETAMINOPHEN | NOT SPECIFIED | Concomitant | |||||
| CLONAZEPAM | TABLET | Concomitant | |||||
| EPIVAL | NOT SPECIFIED | Concomitant | |||||
| SALBUTAMOL | NOT SPECIFIED | Concomitant | |||||
| SEROQUEL | TABLET | Concomitant | |||||
| VENLAFAXINE XR | CAPSULE, SUSTAINED-RELEASE | Concomitant | |||||
| XENICAL 120MG CAPSULE | CAPSULE | Concomitant | |||||
| ZOPICLONE | TABLET | Concomitant | |||||
| DIPHENHYDRAMINE | NOT SPECIFIED | Drug used to treat AE | Oral | 25 Milligram | 3 every 1 Day(s) |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Erythema | |
| Urticaria | |